Back to Search Start Over

Understanding basal cell adenocarcinoma of the head and neck: Population‐based study.

Authors :
Ahsanuddin, Salma
Jin, Ryan
Sheorey, Lena
Sawhney, Rohan
Sangal, Neel R.
Baredes, Soly
Park, Richard Chan Woo
Source :
Head & Neck; Feb2022, Vol. 44 Issue 2, p483-493, 11p
Publication Year :
2022

Abstract

Background: Using a population‐based database, this study investigates the risk factors, epidemiology, and outcomes of basal cell adenocarcinoma (BCAC) of the head and neck. Methods: The Surveillance, Epidemiology, and End Results database was analyzed for all patients with BCAC of the head and neck from 1973 to 2015. Results: Three hundred and twenty‐two cases of BCAC of the head and neck were identified. Mean age of diagnosis was 64.1 years. 52.5% were male and 77.3% were white. The most common primary site was the parotid gland (71.7%). Most patients underwent surgery alone (51.9%). Five‐year disease‐specific survival (5Y‐DSS) was 95.6%, and 10Y‐DSS was 90.3%. Highest survival was seen with surgery alone followed by combined surgery and radiation (10Y‐DSS: 93.9% vs. 88.9%, p = 0.001). Age, primary site, T‐classification, grade, and treatment type significantly affected survival. Conclusions: BCAC of the head and neck presents most frequently in the parotid glands. Surgery alone is associated with highest survival. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
10433074
Volume :
44
Issue :
2
Database :
Complementary Index
Journal :
Head & Neck
Publication Type :
Academic Journal
Accession number :
154715756
Full Text :
https://doi.org/10.1002/hed.26955